Editors: Islam M. Ghazi, Michael J. Cawley

Series Title: Frontiers in Anti-Infective Agents

21st Century Challenges in Antimicrobial Therapy and Stewardship

Volume 3

eBook: US $129 Special Offer (PDF + Printed Copy): US $206
Printed Copy: US $142
Library License: US $516
ISSN: 2705-1072 (Print)
ISSN: 2705-1080 (Online)
ISBN: 978-981-14-6181-1 (Print)
ISBN: 978-981-14-6183-5 (Online)
Year of Publication: 2020
DOI: 10.2174/97898114618351200301
(1 Comment) | Rate This Book

Introduction

21st Century Challenges in Antimicrobial Therapy and Stewardship addresses selected topics that are of importance in the practice of infectious disease management. The text starts by illustrating the global landscape of antimicrobial drug resistance, which influences antimicrobial use and therapeutic decisions in the clinic. The contributors explain the reasons for the spread of antibiotic resistance, the pharmacology of antibiotics of different classes, innovative drug delivery methods which can improve the efficacy and safety of new drug candidates and achieve targeted drug delivery as well as drug resistance monitoring techniques and issues in the practice of antimicrobial stewardship and infection control.

Key Features:

- 14 organized chapters on several aspects of antimicrobial therapy and stewardship

- Introductory knowledge on global antimicrobial trends

- Coverage of molecular basis of antimicrobial resistance in gram positive, gram negative and fungal microbes

- Focused coverage on new developments in antimicrobial drug development, drug delivery, formulation and diagnostic tools

- Information on unmet needs of patients and clinicians, including the treatment of difficult infections

- Comprehensive coverage of issues in antimicrobial stewardship

21st Century Challenges in Antimicrobial Therapy and Stewardship brings to readers – healthcare administrators, educators, pharmacists, clinicians and students, alike – the knowledge of the molecular basis of antimicrobial drug therapy, drug resistance in pathogens and current practices in antimicrobial stewardship programs. This knowledge, in turn, fosters an awareness among healthcare industry participants to collaborate in an interprofessional environment to combat multidrug resistance.

Contributors

Editor(s):
Islam M. Ghazi
Phialdelphia College of Pharmacy
University of the Sciences Philadelphia
Philadelphia
USA


Michael J. Cawley
Phialdelphia College of Pharmacy
University of the Sciences Philadelphia
Philadelphia
USA




Contributor(s):
Abrar K. Thabit
Pharmacy Practice Department, Faculty of Pharmacy
King Abdulaziz University
Jeddah
Saudi Arabia


Adebowale O. Adeluola
Department of Pharmaceutical Microbiology and Biotechnology
Faculty of Pharmacy, College of Medicine campus, University of Lagos
Lagos
Nigeria


Addison Pang
Providence Health & Services
Portland, OR
USA


Ahmed F. El-Yazbi
Department of Pharmacology and Toxicology
Faculty of Pharmacy, Alexandria University
Egypt
/
Department of Pharmacology and Toxicology, Faculty of Medicine and Medical Center
the American University of Beirut
Beirut
Lebanon


Alaa Abouelfetouh
Department of Microbiology and Immunology, Faculty of Pharmacy
Alexandria University
Alexandria
Egypt


Alyssa Christensen
Providence Health & Services
Portland, OR
USA


Benjamin Georgiades
Shionogi Inc
Florham Park, NJ
USA


Diaa Alrahmany
Inpatient Pharmacy
Sohar Hospital
Sultanate of Oman


Elisa Morgan
Doylestown Hospital
595 W State St, Doylestown, PA, 18901
USA


Elsayed Aboulmagd
Department of Microbiology and Immunology, Faculty of Pharmacy
Alexandria University
Alexandria
Egypt


Enas A. Almohammadi
Pharmacy Practice Department, Faculty of Pharmacy
King Abdulaziz University
Jeddah
Saudi Arabia


Hadeel N. Alshaikh
Pharmacy Practice Department, Faculty of Pharmacy
King Abdulaziz University
Jeddah
Saudi Arabia


Islam M. Ghazi
Phialdelphia College of Pharmacy
University of the Sciences Philadelphia
Philadelphia
USA


Janise Philllips
Department of Pharmacy Services
Houston Methodist Willowbrook
Houston, Texas
USA


Jonathan C. Cho
Mountain View Hospital
Las Vegas, NV
USA


Kamilia Abdelraouf
Center of Anti-infective Research and Development
Hartford Hospital
Hartford, Connecticut
USA


Kolawole S. Oyedeji
Department of Medical Laboratory Science
University of Lagos
Lagos
Nigeria


Lamia S. Alzahrani
Pharmacy Practice Department, Faculty of Pharmacy
King Abdulaziz University
Jeddah
Saudi Arabia


Lucia Rose
Cooper University Hospital
Camden, NJ, 08103
USA


Madeline King
University of the Sciences - Philadelphia College of Pharmacy
Philadelphia, PA, 19104
USA


Mervat A. Kassem
Department of Microbiology and Immunology, Faculty of Pharmacy
Alexandria University
Alexandria
Egypt


Michael J. Cawley
Philadelphia College of Pharmacy/University of the Sciences
Philadelphia, PA
USA


Morgan Anderson
Advocate Aurora Health
Downers Grove, IL
USA


Nesrine Rizk
Division of Infectious Diseases, Department of Internal Medicine and Medical Center
the American University of Beirut
Beirut
Lebanon


Nisrine Haddad
Department of Pharmacy
the American University of Beirut Medical Center
Beirut
Lebanon


Nizar Attallah
Department of Nephrology
Cleveland Clinic Abu Dhabi
Abu Dhabi
UAE


Pardeep Gupta
Department of Pharmaceutics
University of the Sciences
Philadelphia
USA


Rebecca L. Dunn
The University of Texas at Tyler Fisch College of Pharmacy
Tyler, TX
USA


Rim W. Rafeh
Department of Pharmacology and Toxicology, Faculty of Medicine and Medical Center
the American University of Beirut
Beirut
Lebanon


Sean Nguyen
Shionogi Inc
Florham Park, NJ
USA


Takova D. Wallace-Gay
The University of Texas at Tyler Fisch College of Pharmacy
Tyler, TX
USA


Vaishnavi Parikh
Department of Pharmaceutics
University of the Sciences
Philadelphia
USA


Viktorija O. Barr
Rosalind Franklin University
North Chicago, IL
USA
/
T2Biosystems
Lexington, MA
USA


Wasim S. El Nekidy
Department of Pharmacy
Cleveland Clinic Abu Dhabi
Abu Dhabi
UAE




RELATED BOOKS

.Coronaviruses.
.COVID-19: Current Challenges and Future Perspectives.
.Tuberculosis: A Clinical Practice Guide  .
.The COVID-19 Pandemic: Epidemiology, Molecular Biology and Therapy.